DCVC Opportunity Fund II GP, LLC — Q3 2024 13F-HR

← DCVC Opportunity Fund II GP, LLC

Q3 2024 · 13F-HR

DCVC Opportunity Fund II GP, LLCholdings as filed

Filed 2024-11-14 · accession 0001104659-24-118270

$97.4M

Reported value

Positions

2024-09-30

Period end

View analyzed profile →PRO

The Brief · DCVC Opportunity Fund II GP, LLC · Q3 2024

AI · grounded in 13F

DCVC Opportunity Fund II GP, LLC reported no changes to its 13F holdings for 2024-09-30 relative to 2024-06-30.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
773122106	—	Rocket Lab USA, Inc.	$70.1M	72.0%	7,203,035	Common	SOLE
75629V104	RXRX	Recursion Pharmaceuticals, Inc.	$26.0M	26.7%	3,951,141	Common	SOLE
76655K103	RGTI	Rigetti Computing, Inc.	$1.3M	1.29%	1,599,052	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.